This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/526203-taiwan-vaccines-astrazeneca-covid19/
The article has changed 3 times. There is an RSS feed of changes available.
Version 0 | Version 1 |
---|---|
Taiwan says deal to manufacture AstraZeneca Covid jab fell through as production demands were too high | Taiwan says deal to manufacture AstraZeneca Covid jab fell through as production demands were too high |
(3 months later) | |
Taiwan’s health minister has said the country came close to reaching a deal with AstraZeneca to produce its Covid-19 jab on the island, but a potential agreement fell through, with the company’s demands being too high. | Taiwan’s health minister has said the country came close to reaching a deal with AstraZeneca to produce its Covid-19 jab on the island, but a potential agreement fell through, with the company’s demands being too high. |
Speaking in parliament on Thursday, Health Minister Chen Shih-chung had proposed producing 100 million doses on behalf of AstraZeneca, but the company was only willing to accept a minimum of 300 million doses. | Speaking in parliament on Thursday, Health Minister Chen Shih-chung had proposed producing 100 million doses on behalf of AstraZeneca, but the company was only willing to accept a minimum of 300 million doses. |
“We considered that it would be difficult and would fully occupy production lines. It’s not possible for Taiwan to consume so much,” he told lawmakers. | “We considered that it would be difficult and would fully occupy production lines. It’s not possible for Taiwan to consume so much,” he told lawmakers. |
On Tuesday, Chen said that production problems at AstraZeneca’s Thailand plant, where the jab is being made by royal-owned Siam Bioscience, would delay deliveries. | On Tuesday, Chen said that production problems at AstraZeneca’s Thailand plant, where the jab is being made by royal-owned Siam Bioscience, would delay deliveries. |
The island has been desperately hunting for more vaccines having blamed China for compromising their negotiations with vaccine producers. Last week, Japan donated more than a million Covid-19 shots to Taiwan, more than doubling Taipei’s vaccine stocks. | The island has been desperately hunting for more vaccines having blamed China for compromising their negotiations with vaccine producers. Last week, Japan donated more than a million Covid-19 shots to Taiwan, more than doubling Taipei’s vaccine stocks. |
To date, only around 3% of Taiwan’s 23.5 million people have received at least one shot as the government battles to contain a spike in domestic infections. | To date, only around 3% of Taiwan’s 23.5 million people have received at least one shot as the government battles to contain a spike in domestic infections. |
The government has a further 20 million jabs on order and is developing its own domestic vaccine. Despite pressure from opposition groups, Taipei has refused to accept vaccines from Beijing, which considers the island an integral part of its territory. | The government has a further 20 million jabs on order and is developing its own domestic vaccine. Despite pressure from opposition groups, Taipei has refused to accept vaccines from Beijing, which considers the island an integral part of its territory. |
If you like this story, share it with a friend! | If you like this story, share it with a friend! |
Dear readers and commenters, | |
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
Sorry for the inconvenience, and looking forward to your future comments, | |
RT Team. |